Price Alert

Tourmaline Bio Inc. (TRML)

NASDAQ: TRML · Real-Time Price · USD

47.87

0.04 (0.08%)

At close: Oct 01, 2025, 3:52 PM

Company Description

Tourmaline Bio, Inc. operates as a clinical biotechnology company that develops medicines for patients with life-altering immune diseases.

It develops medicines and therapies for the Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED).

The company was incorporated in 2021 and is based in New York, New York.

Tourmaline Bio Inc.

Address: 27 West 24th Street New York City, New York United States
Website	https://www.tourmalinebio.com

Name	Position
Dr. Sandeep C. Kulkarni M.D.	Co-Founder, Chief Executive Officer & Director
Dr. Susan Dana Jones Ph.D.	Chief Technology Officer
Ryan Robinson CPA	Chief Financial Officer & Treasurer
Dora Rau	Senior Vice President & Head of Quality
Dr. Emil M. deGoma M.D.	Senior Vice President of Medical Research
Dr. Kevin B. Johnson M.B.A., Ph.D.	Chief Regulatory Officer
Dr. Kristine Erickson O.D., Ph.D.	Vice President & TA Head of Ophthalmology, Medical Research
Gerhard Hagn Pharm.D.	Senior Vice President and Head of Commercial & Business Development
Kimberly Piorkowski	Vice President of People, Culture & Compliance
W. Bradford Middlekauff J.D.	Chief Business Officer, General Counsel & Corporate Secretary